The use of immunoglobulins in the treatment of human epilepsy

Neurological Sciences

Volumn 23, Issue SUPPL. 1, 2002, Pages

  Villani, F ^a   Avanzini, G ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINUCLEAR ANTIBODY; ANTIVIRUS AGENT; AUTOANTIBODY; CARBAMAZEPINE; CORTICOSTEROID; CORTICOTROPIN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA; MOLECULAR MARKER; PHENYTOIN; STEROID;

ANTICONVULSANT ACTIVITY; ARTICLE; CELL LEVEL; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EXPERIMENTAL MODEL; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INTRACTABLE EPILEPSY; NEUROPATHOLOGY; NONHUMAN; SEIZURE;

BLOOD-BRAIN BARRIER; ENCEPHALITIS; EPILEPSY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INFANT, NEWBORN; LANDAU-KLEFFNER SYNDROME; SPASMS, INFANTILE; TREATMENT OUTCOME;

EID: 0036266629     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720200013     Document Type: Article

References (48)

1. Traitement des encephalopathies epileptiques de l'enfant par les gammaglobulines
2. The allergic approach to epilepsy: A critical review
3. Allergic phenomena as basic mechanism in epilepsy
4. Neuroendocrine-immune interactions
5. Immunoglobulin treatment in epilepsy, a review of the literature
6. Immunological aspects of epilepsy
7. Unexpected improvement of intractable epilepsy following infections
8. Intravenous immunoglobulin and pyridoxin-dependent seizures
9. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network
10. Agammaglobulinemias
11. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
12. Passage of intravenous immunoglobulin and interaction with the CNS
13. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin
14. Evidence for the movement of fluid, macromolecules and ions from the brain extracellular space to the CSF
15. Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents
16. IgA deficiency, epilepsy and hydantoin medication
17. IgG2 deficiency and intractable epilepsy of childhood
18. Immunological evaluation of patients with infantile spasms
19. Immunological studies in focal epilepsy
20. Immunoglobulin treatment in human and experimental epilepsy
21. Serologic HLA typing in infantile spasms
22. Glycerol-induced seizure: Involvement of IL-1β and glutamate
23. Cytokine production in blood mononuclear cells from epileptic patients
24. Interleukin (IL) 1β, IL-1α, and IL-1 receptor antagonist polymorphisms in patients with temporal lobe epilepsy
25. Polymorphism of the interleukin-1 gene complex in localization-related epilepsy
26. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures
27. Epileptiform activity evoked by intracerebral injection of antibrain antibodies
28. Anti-CNS antibodies in childhood neurologic diseases
29. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus
30. Cryptogenic partial epilepsy with anti-GM1 antibodies: A new form of immune-mediated epilepsy?
31. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis
32. Immunologic aspects of carbamazepine treatment in epileptic patients
33. Antiepileptic effects of globulin-N, an intact human immunoglobulin and its tissue-distribution in kindled cats
34. Treatment of idiopathic West and Lennox-Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins
35. Immunoglobulin therapy in the West syndrome
36. Intravenous immunoglobulin: A single blind trial in children with Lennox-Gastaut syndrome
37. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndromes; an add-on study
38. Intravenous immune globulin in the treatment of intractable childhood epilepsy
39. Treatment of infantile spasms
40. Lennox-Gastaut syndrome and myoclonic epilepsies of infancy and early childhood
41. A role of autoimmunity in the etiopathogenesis of Landau-Kleffner syndrome?
42. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders
43. Landau-Kleffner syndrome: Consistent response to repeated intravenous gammaglobulin doses: A case report
44. Successful use of IVIG in Landau-Kleffner syndrome
45. Successful use of intravenous immunoglobulin as initial monotherapy in Landau-Kleffner syndrome
46. Chronic encephalitis, epilepsy, and cerebrovascular immune complex deposits
47. Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy
48. Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis